Skip to main content
. Author manuscript; available in PMC: 2014 Jun 5.
Published in final edited form as: Hypertension. 2009 Jul 20;54(3):639–645. doi: 10.1161/HYPERTENSIONAHA.108.126664

Figure 2.

Figure 2

Systolic blood pressure measured by radiotelemetry in (a) 15–17 week old SHR and SHR-18, (b) 19–21 week old SHR and SHR-18A, (c) 15–17 week old SHR and SHR-18B, (d) 15–17 week old SHR and SHR-18C strains. Baseline systolic blood pressure was significantly reduced in SHR-18 (F1,12=4.84; P=0.048), SHR-18A (F1,12=10.17; P=0.008) and SHR-18B (F1,11=12.6; P=0.005). No significant reduction in systolic blood pressure was obtained in SHR-18C (F1,11=0.27; P=0.61) strain vs SHR. All results according to main effect F values of two way repeated measures ANOVA are reported. Salt-loaded systolic blood pressure was significantly raised in all SHR and congenic strains SHR-18A (F1,6 =27.7; P= 0.002), SHR-18B (F1,4 =57.3; P= 0.0016) and SHR-18C (F1,6 =10.3; P= 0.019) with the exception of SHR-18: SHR-18 (F1,7 =0.88; P= 0.38). All F values computed for contrast comparison in two-way ANOVA. The baseline period is from −12 to −2 days and salt administration from day 1 as indicated. Values displayed are means ± SEM.